Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Columbia Protocol for Malignant Pleural Mesothelioma
NCT00859495Phase 2Terminated
- Sponsor
- Columbia University
- Start
- Feb 2008
- Primary completion
- Feb 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, cisplatin, pemetrexed in malignant pleural mesothelioma (MPM), sponsored by Columbia University. Started Feb 2008; status: terminated.
02
Drugs
doxorubicincisplatinpemetrexed
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00859495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859495.